Ann Surg Oncol

1. UGUR R, Demiriz B, Nisli O, Keskin ET, et al
   ASO Visual Abstract: Who is at Risk of Residual Tumor and Pathologic Upstaging at Second TURBT in Non-Muscle-Invasive Bladder Cancer?
   Ann Surg Oncol. 2026 Aug 1. doi: 10.1245/s10434-026-20351.
   

   >> Share

   
   
2. AYDOGDU C, Wang B, McSweeney S, Pieretti A, et al
   ASO Visual Abstract: Preoperative Tumor-Informed ctDNA for Prediction of Nodal Metastases at Radical Cystectomy in Bladder Cancer.
   Ann Surg Oncol. 2026 Aug 4. doi: 10.1245/s10434-026-20121.
   

   >> Share

   
   

   
   Aust Vet J

3. TEH A, Sima T, Shinozaki E, Malik R, et al
   A case of canine urothelial carcinoma of the urinary bladder with skull and skeletal metastases.
   Aust Vet J. 2026;104:509-514.
   

   >> Share

   
   

   
   BJC Rep

4. DEZA I, de Lacy Costello B, Drabinska-Fois N, White P, et al
   Urinary volatilomics using liquid-liquid extraction and gas chromatography-mass spectrometry (GC-MS) combined with machine learning algorithms as a tool for diagnosis and surveillance of urothelial bladder cancer.
   BJC Rep. 2026;4:42.
   

   >> Share

   
   

   
   BJUI Compass

5. AYDIN A, Abdulmajeed AS, Bekiroglu FB, Kocak M, et al
   Investigating gender disparities in urological care for non-muscle invasive bladder cancer (NMIBC).
   BJUI Compass. 2026;7:e70245.
   

   >> Share

   
   

   
   BMC Urol

6. THAI KL, Le PND, Nguyen TT, Ngo XT, et al
   Clinical and imaging predictors of urachal carcinoma: the role of gross hematuria and calcification in a single-center retrospective study.
   BMC Urol. 2026;26:190.
   

   >> Share

   
   
7. SUARTZ CV, Azevedo MFD, Brito PHS, Setoue DND, et al
   Evolution of treatment and oncological outcomes in patients undergoing radical cystectomy: a comparative analysis across two decades at a tertiary center.
   BMC Urol. 2026;26:189.
   

   >> Share

   
   

   
   BMJ Open

8. AGHAMIR SMK, Rahimnia R, Taheri D, Ebrahimi M, et al
   Prognostic value of different biomarkers in bladder cancer: protocol for an umbrella review of systematic reviews and meta-analyses.
   BMJ Open. 2026;16:e118810.
   

   >> Share

   
   

   
   Cancer

9. WALKER CH, Jabalameli N, Rais-Bahrami S
   Radiomic phenotypes in nonmuscle-invasive bladder cancer: A precision biomarker guiding therapy.
   Cancer. 2026;132:e70563.
   

   >> Share

   
   

   
   Cancer Imaging

10. WOO S, Muglia VF, Luk L, Takeuchi M, et al
    What's next for VI-RADS? Updates and future perspectives from the ACR VI-RADS steering committee.
    Cancer Imaging. 2026;26:97.
    

    >> Share

    
    

    
    Cancer Immunol Immunother

11. YEH CC, Fan CS, Chen LL, Chua KV, et al
    Preclinical evaluation of rBCG-h12: an engineered Bacillus Calmette-Guerin with an enhanced activity against bladder and pancreatic cancers.
    Cancer Immunol Immunother. 2026;75:202.
    

    >> Share

    
    

    
    Cancer Sci

12. MATSUBARA N, Saijo K, Shimizu Y, Okano S, et al
    First-In-Human Study: Dose Expansion of E7130 in Urothelial Carcinoma and Squamous Cell Carcinoma of the Head and Neck.
    Cancer Sci. 2026;117:2247-2258.
    

    >> Share

    
    
13. CHEN Y, Jiang Y, Yang Z, Jing M, et al
    LAMC2(+) Epithelial Cells Drive Bladder Cancer Progression and Predict Immunotherapy Response via SERPINB3/STAT3/CD44 Axis.
    Cancer Sci. 2026 Aug 5:10.1111/cas.70492. doi: 10.1111/cas.70492.
    

    >> Share

    
    

    
    Case Rep Oncol Med

14. SAAD A, Daraan FM, Barghouth I, Sleiay M, et al
    Complete Response to Intravesical BCG for High-Risk pT1 Bladder Cancer With Lymphovascular Invasion: A Case Report.
    Case Rep Oncol Med. 2026;2026:7517129.
    

    >> Share

    
    

    
    Clin Genitourin Cancer

15. YANG X, Cai L, Wang C, Tan Z, et al
    The Prognostic Role of HER2 Expression in Patients With Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2026;24:102624.
    

    >> Share

    
    

    
    Clin Transl Radiat Oncol

16. TILKI B, Guler OC, Demirhan B, Hurmuz P, et al
    Stereotactic body radiotherapy for bone-only oligometastatic bladder Cancer: a multi-institutional experience.
    Clin Transl Radiat Oncol. 2026;60:101246.
    

    >> Share

    
    

    
    Colloids Surf B Biointerfaces

17. ZENG Z, Hu C, Li Y, Ding B, et al
    Smart nanoplatform targeting the mitochondria-P-gp axis to overcome chemoresistance for synergistic bladder cancer therapy.
    Colloids Surf B Biointerfaces. 2026;268.
    

    >> Share

    
    

    
    Crit Rev Oncol Hematol

18. SAAD MA, Antari A, Taleb I, El Omri S, et al
    Bacillus Calmette-Guerin (BCG) with or without immune checkpoint blockade in BCG-naive high-risk non-muscle-invasive bladder cancer: A systematic review and reconstructed individual patient data meta-analysis.
    Crit Rev Oncol Hematol. 2026;227:105510.
    

    >> Share

    
    

    
    Cureus

19. GOH NS
    Presumed Simultaneous Intraocular and Extraocular BCG-osis as a Complication of Intravesical Bacillus Calmette-Guerin Treatment for Non-Muscle-Invasive Bladder Cancer: A Case Report.
    Cureus. 2026;18:e114020.
    

    >> Share

    
    

    
    Eur Urol Oncol

20. SFORZA S, Lubbersmeyer F, Mari A
    Prognostic Factors After Radical Cystectomy for Non-muscle-invasive Bladder Cancer: From Prognostication to Patient Selection.
    Eur Urol Oncol. 2026 Aug 7:S2588-9311(26)00200-2. doi: 10.1016/j.euo.2026.
    

    >> Share

    
    
21. ST-LAURENT MP, Eigl BJ, Tyldesley S, Yuan R, et al
    NeoBLAST: A Pilot Randomized Controlled Trial of Active Surveillance Versus Definitive Bladder Treatment Following Clinical Complete Response to Neoadjuvant Therapy in Muscle-invasive Bladder Cancer - Study Protocol.
    Eur Urol Oncol. 2026 Aug 7:S2588-9311(26)00198-7. doi: 10.1016/j.euo.2026.
    

    >> Share

    
    
22. MALMSTROM PU, Dragomir A, Gardmark T
    Validation of an AI-based Histologic Prognostic Biomarker in Patients with Non-muscle-invasive Bladder Cancer Using the Prospective Swedish National Register of Urinary Bladder Cancer.
    Eur Urol Oncol. 2026 Aug 4:S2588-9311(26)00192-6. doi: 10.1016/j.euo.2026.
    

    >> Share

    
    

    
    Eur Urol Open Sci

23. RUTTEN VC, van Rijen NMA, Franckena M, Robbrecht DGJ, et al
    Real-world Impact of Integrating Comprehensive Geriatric Assessment into Clinical Treatment Decision-making for Older Patients with Bladder Cancer.
    Eur Urol Open Sci. 2026;91:23-31.
    

    >> Share

    
    

    
    Expert Rev Anticancer Ther

24. AL ARMASHI AR, Gong J, Barata P, Brown J, et al
    Immune checkpoint inhibitors in urothelial carcinoma: a practical framework for patient selection, toxicity management, response assessment, and treatment sequencing.
    Expert Rev Anticancer Ther. 2026;26:1003-1017.
    

    >> Share

    
    

    
    Explor Target Antitumor Ther

25. FUKUHARA H, Shimasaki S, Yamashita E, Kurano Y, et al
    Transurethral laser ablation using 980-nm diode laser for recurrent non-muscle invasive bladder cancer.
    Explor Target Antitumor Ther. 2026;7:1002386.
    

    >> Share

    
    

    
    Front Genet

26. DONG X, Chen Z, Chen Y, Xiao Z, et al
    Mechanical stress, metabolic reprogramming and stromal remodeling: an emerging paradigm in the bladder cancer mechano-micro-environment.
    Front Genet. 2026;17:1896399.
    

    >> Share

    
    

    
    Front Immunol

27. DIAO X, Che B, Zhai J, Shao B, et al
    Decoding the temporal dimension of innate immunity in intravesical BCG therapy.
    Front Immunol. 2026;17:1904049.
    

    >> Share

    
    

    
    Gan To Kagaku Ryoho

28. HORI J, Tokumitsu M, Yamaguchi S, Ishida H, et al
    [Outcome of Eight-Year-Experiences of BCG Intravesical Instillation Therapy in Patients with Non-Muscle Invasive Bladder Cancer in Asahikawa Medical University Hospital].
    Gan To Kagaku Ryoho. 2026;53:407-412.
    

    >> Share

    
    

    
    Histol Histopathol

29. KITAHAMA K, Inamura K
    Inverted urothelial papilloma: Diagnostic challenges, molecular insights, and clinical implications.
    Histol Histopathol. 2026;41:1483-1491.
    

    >> Share

    
    

    
    Int J Surg Pathol

30. LEE T, Akgul M, Fernandez-Pol S, Aron M, et al
    Immunohistochemical Expression of p63 and GATA3 in Lymphomas of the Urinary Bladder: A Clinicopathologic Study of a Potential Diagnostic Pitfall.
    Int J Surg Pathol. 2026;34:1483-1488.
    

    >> Share

    
    
31. MITRA S, Shangloo A, Bhatkule MA, Akif S, et al
    Complete Colonic Metaplasia of the Urinary Bladder and Ureters With Primary Signet-Ring Cell Adenocarcinoma of the Urinary Bladder: A Rare Occurrence.
    Int J Surg Pathol. 2026;34:1630-1635.
    

    >> Share

    
    
32. POLAT UNAL SE, Suren D, Kurtoglu E
    Primary Classical Hodgkin Lymphoma of the Urinary Bladder: Expanding the Spectrum of Bladder Lymphoid Neoplasms.
    Int J Surg Pathol. 2026;34:1586-1590.
    

    >> Share

    
    
33. BUDINA A, Vergara N, Navarro FE, Morrissette JJD, et al
    High-Grade Urothelial Carcinoma with Divergent Prostatic Differentiation Mimicking a Collision Tumor in a Bladder Diverticulum.
    Int J Surg Pathol. 2026;34:1570-1578.
    

    >> Share

    
    
34. GRYPARI IM, Pomoni A, Ganetsou D, Kouroukli O, et al
    True Papillae and Squamous Features in Prostate Carcinoma Represent a Potential Diagnostic Pitfall: Report of 3 Patients.
    Int J Surg Pathol. 2026;34:1610-1615.
    

    >> Share

    
    

    
    J Clin Invest

35. MORENO-VEGA A, Zambrano M, Estrada-Virrueta L, Meng X, et al
    FGFR3-driven gene regulatory network analysis reveals a protumoral role for p63 in luminal bladder tumors.
    J Clin Invest. 2026;136:e193280.
    

    >> Share

    
    

    
    J Robot Surg

36. ELEFTHERIOU C, Zhao Y, Lami M, Boaz RJ, et al
    Comparison of postoperative and early oncological outcomes of open versus robotic radical cystectomy.
    J Robot Surg. 2026;20:808.
    

    >> Share

    
    
37. XU Z, Wang X
    Intracorporeal urinary diversion during robot-assisted radical cystectomy: a bibliometric and visualization analysis of research evolution, evidence landscape, learning curves, and clinical outcomes.
    J Robot Surg. 2026;20:806.
    

    >> Share

    
    

    
    Jpn J Clin Oncol

38. IKEHATA Y, Nishiyama N, Miyake M, Nishimura N, et al
    Prognostic significance of non-muscle-invasive late recurrence after intravesical bacillus Calmette-Guerin therapy in bladder cancer: a multicenter, retrospective real-world study (the Japan Urological Oncology Group).
    Jpn J Clin Oncol. 2026 Aug 7:hyag124. doi: 10.1093.
    

    >> Share

    
    

    
    JU Open Plus

39. TYSON MD 2ND, Choudry MM, McKee C, Kalaria S, et al
    Health Care Utilization and Costs Associated With Blue-Light vs White-Light Cystoscopy: A Real-World Bladder Cancer Population.
    JU Open Plus. 2026;4:e00085.
    

    >> Share

    
    

    
    Med Sci Monit

40. XU J, Huang Y, Ni G, Huang Y, et al
    Hemostatic Efficacy and Clinical Outcomes of Radiotherapy in Older Adult Patients With Advanced Bladder Cancer and Hematuria Unsuitable for Standard Treatment.
    Med Sci Monit. 2026;32:e953113.
    

    >> Share

    
    

    
    Mol Biol Rep

41. ZHANG S, Li M, Wu Y, Kang Y, et al
    Circ_0001495 promotes bladder cancer progression by regulating miR-1184 via MAPK signaling pathway.
    Mol Biol Rep. 2026;53:1337.
    

    >> Share

    
    

    
    Mol Cancer Ther

42. TANAKA N, Miyajima A, Kosaka T, Shirotake S, et al
    Editor's Note: Cis-dichlorodiammineplatinum Upregulates Angiotensin II Type 1 Receptors through Reactive Oxygen Species Generation and Enhances VEGF Production in Bladder Cancer.
    Mol Cancer Ther. 2026;25:1410.
    

    >> Share

    
    

    
    Mol Carcinog

43. ZHOU L, Zhu J, Liu Y, Xu B, et al
    Integrated Immunological Analysis of Interactions Between CXCL13+ T Cells and LAMP3+ DC in the Immunotherapy Response of Bladder Cancer.
    Mol Carcinog. 2026 Aug 5. doi: 10.1002/mc.70162.
    

    >> Share

    
    

    
    Nat Commun

44. EINERHAND SMH, Ali H, Wong SQ, van Dorp J, et al
    Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial.
    Nat Commun. 2026;17:7679.
    

    >> Share

    
    

    
    Nat Rev Urol

45. HENSLEY PJ, Teoh JYC, Li R, Gupta S, et al
    Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.
    Nat Rev Urol. 2026 Aug 5. doi: 10.1038/s41585-026-01179.
    

    >> Share

    
    
46. SCILIPOTI P, Rosiello G, Salonia A, Briganti A, et al
    Beyond surgical technique: modifiable risk factors and evolving treatment paradigms in bladder cancer surgery.
    Nat Rev Urol. 2026 Aug 3. doi: 10.1038/s41585-026-01180.
    

    >> Share

    
    

    
    Nutrition

47. KIEBACH J, Kamps CSAD, Wesselink E, Aben KKH, et al
    Lifestyle and dietary inflammation scores and risks of recurrence and progression among patients with non-muscle invasive bladder cancer.
    Nutrition. 2026;151:113354.
    

    >> Share

    
    

    
    Radiol Case Rep

48. GAOL LML, Prabaningrum YSK, Andy, Swity AF, et al
    Atypical desmoplastic small round cell tumor (DSRCT) mimicking muscle-invasive bladder cancer (MIBC) in a child: Surgical approach using ileal diversion.
    Radiol Case Rep. 2026;21:4398-4404.
    

    >> Share

    
    

    
    Scand J Urol

49. HAWEZ L, Bergengren O, Ahlberg M, Garmo H, et al
    Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden.
    Scand J Urol. 2025;60:204-208.
    

    >> Share

    
    

    
    Sci Adv

50. ZUO J, Tan Y, Mu Z, Dong Y, et al
    Assembly-formed bioorthogonal chimeric artificial receptors enable high-contrast fluorescence imaging of tumors.
    Sci Adv. 2026;12:eaed9403.
    

    >> Share

    
    

    
    Transpl Infect Dis

51. VARANASI P, Wengenack N, Steidley DE, Kodali L, et al
    Disseminated Mycobacterium bovis-BCG Infection Following Intravesical BCG Administration in Solid Organ Transplant Recipients.
    Transpl Infect Dis. 2026;28:e70220.
    

    >> Share

    
    

    
    Urol Res Pract

52. DOLEK EK, Biyikoglu M, Cayan S, Senel S, et al
    The Effect of Intravesical Bacillus Calmette-Guerin Treatment on Sexual Functions and Mental Health in Male and Female Patients Diagnosed with Non-Muscle Invasive Bladder Cancer.
    Urol Res Pract. 2026;52:1-8.
    

    >> Share

    
    

    
    Urologia

53. ILMIAH K, Parengkuan IL, Rahaju AS, Mastutik G, et al
    Bladder Urothelial Neoplasms Profile in Dr. Soetomo General Academic Hospital Surabaya: Retrospective Study during 2013-2023.
    Urologia. 2026;93:384-388.
    

    >> Share

    
    
54. ILKTAC A, Dogan B, Gevher F, Akcay M, et al
    Hematuria-related readmission after transurethral resection of bladder tumor in patients receiving antiplatelet therapy.
    Urologia. 2026;93:370-375.
    

    >> Share

    
    
55. JAVID RAJA IYUB M, Prabhakar P, Pon Avudaiappan A, Sakthivel DK, et al
    Postoperative ileus following radical cystectomy in current urological practice: Incidence and risk factors.
    Urologia. 2026;93:376-383.
    

    >> Share

    
    

    
    Vet J

56. MUSCATELLO LV, Bacci B, Brigandi E, Tugnoli C, et al
    Computer-aided image analysis for PD-L1 assessment in canine urothelial carcinoma.
    Vet J. 2026;318:106758.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share